COUNTRY REPORT 2013
Rabies diagnostics and surveillance
(SEARG)
Country report for
Presented by
Please provide all the information requested in the format guide below and feel free
to add additional information or clarifications
1. Rabies diagnostics
Please provide a brief discussion of rabies diagnostics. In each case
(animal/human rabies), please state the laboratory location, infrastructure,
capacity and type(s) of diagnostic method used
1.1 Animal rabies
1.2 Human rabies
2. Submission forms and Storage of samples
2.1 Please attach an example of any submission forms that are submitted
with samples for rabies testing at your laboratories
2.2 Please describe the strategy for the storage of tested samples in the
different laboratories.
3.
Number of tests and cases: Animal rabies
For animal specimens investigated in your laboratory, please indicate the
numbers examined (2010-2012) and those found as either rabies positive or
negative.
2010
2011
2012
2010
2011
2012
Number of dogs tested
Dogs rabies positive
Dogs rabies negative
Number of other domestic animals tested
Animals rabies positive
Animals rabies negative
Number of wildlife tested
Wildlife rabies positive
Wildlife rabies negative
Total number of positive rabies cases
4. Number of tests and cases: Human rabies
4.1 Please complete the Table below
Total number of human rabies deaths
confirmed by laboratory tests
Total number of human rabies deaths
diagnosed on clinical grounds only
Total number of people bitten by dogs (dog
bite registers)
4.2 Please provide any other relevant information on cases, including the
source of exposure, age distribution etc.
a. Please indicate the number of people bitten by suspected dogs. #
5. Vaccine use in the control of rabies
a. Is rabies a notifiable disease in humans and animals in your
country? Please specify.
b. Please describe your national policy and regulations regarding
rabies, including measures for disease control in animals and humans.
c. Use of veterinary vaccines (doses/amount) according to vaccine
type.
2010
2011
2012
Nerve Tissue Vaccines produced
Nerve Tissue Vaccines administered
Cell culture vaccines produced
Cell culture vaccines imported
Cell culture vaccines administered
Total $ (USD) spent on veterinary
vaccines
d. Use of human vaccines (doses/amount) according to vaccine type.
2010
Nerve Tissue Vaccines produced
Nerve Tissue Vaccines administered
Cell culture vaccines produced
Cell culture vaccines imported
Cell culture vaccines administered
Total number of persons who received
Pre Exposure Prophylaxis
Total number of persons who received
Post Exposure Prophylaxis
Total $ (USD) spent on human
vaccines
2011
2012
e. Use of rabies immunoglobulin (doses/amounts)
2010
2011
2012
Equine rabies immunoglobulin
produced/imported
Human rabies immunoglobulin
produced/imported
Equine rabies immunoglobulin
administered (# of patients)
Human rabies immunoglobulin
administered (# of patients)
Total cost of RIG (USD)
6. Please report any post exposure treatment failures
7. Any other comments or information, including existing national or regional
rabies research projects, collaborations or control programmes
8. How does the 2013 country situation compare with the situation as reported in
2011 (SEARG, Maputo)? Any trends analysis would be meaningful.
9. Contact Information
Please provide the following contact information as of 2013 for up to four
persons most directly concerned with rabies in your country – including aspects
such as rabies research, diagnosis, surveillance, treatment and control.
Please provide full names, current position, contact numbers, email address(es)